The NIDDK-supported Cystic Fibrosis Research and Translation Centers are part of an integrated program of research support designed to enhance multidisciplinary research in pathogenesis and treatment of cystic fibrosis.
Cystic fibrosis-related diabetes (CFRD) is the most common complication of cystic fibrosis. Glucose abnormalities that precede diabetes are even more common, in fact, most adults living with CF have some degree of diabetes or glucose intolerance. Early recognition of the disease and therapeutic intervention may diminish the negative impact that diabetes has on lung health in CF.
The goal of the CF Research and Translation Centers is to support basic, preclinical, and clinical research to advance scientific knowledge and develop and test new therapies for cystic fibrosis.
Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions or a group of institutions with an established, comprehensive research base in cystic fibrosis and cystic fibrosis-related diabetes as well as promote communication and collaboration between basic and clinical researchers to study the multiple organ systems affect by cystic fibrosis.